SYSTEMIC SOLUTIONS, LEGISLATIVE AND ORGANIZATIONAL FRAMEWORKS AIMED TO PREVENT OR MITIGATE DRUG SHORTAGES IN EUROPEAN COUNTRIES
Author(s)
Bochenek T1, Godman BB2, Bucsics A3, De Weerdt E4, Fürst J5, Gailite E6, Hotvedt TA7, Huys I4, Inotai A8, Joppi R9, Malaj A10, Margus K11, Marković-Peković V12, Simoens S4, Slaby J13, Sović Brkičić L14, Gürpınar EU15, Vella Bonanno P16, Warminska EJ17, Pilc A18
1Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland, 2Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK, 3University of Vienna, Vienna, Austria, 4KU Leuven, Leuven, Belgium, 5ZZZS (Health Insurance Institute of Slovenia), Ljubljana, Slovenia, 6State Agency of Medicines, Riga, Latvia, 7Norwegian Medicines Agency, Oslo, Norway, 8Syreon Research Institute, Budapest, Hungary, 9Local Health Unit of Verona – Veneto Region, Verona, Italy, 10University of Medicine Tirana, Tirane, Albania, 11Estonian State Agency of Medicines, Tartu, Estonia, 12Ministry of Health and Social Welfare, Banja Luka, Republic of Srpska, Bosnia and Herzegovina, 13State Institute for Drug Control, Prague, Czech Republic, 14Croatian Health Insurance Fund, Zagreb, Croatia, 15Turkish Medicines and Medical Devices Agency, Ankara, Turkey, 16, Mellieha, Malta, 17, Warsaw, Poland, 18Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland
Conference/Value in Health Info
Value in Health, Vol. 19, No. 7 (November 2016)
Code
PHP34
Topic
Economic Evaluation, Health Policy & Regulatory, Health Service Delivery & Process of Care, Real World Data & Information Systems
Topic Subcategory
Approval & Labeling, Cost/Cost of Illness/Resource Use Studies, Health & Insurance Records Systems, Hospital and Clinical Practices, Prescribing Behavior, Pricing Policy & Schemes
Disease
Multiple Diseases